1. Home
  2. Browse Decisions
  3. F.3d
  4. 630 F.3d
  5. 630 F.3d 263 (2010)
 

IMS HEALTH INC. v. SORRELL

Docket Nos. 09-1913-cv(L), 09-2056-cv(CON).

630 F.3d 263 (2010)

IMS HEALTH INC., Verispan, LLC, Source Healthcare Analytics, Inc., a subsidiary of Wolters Kluwer Health, Inc., and Pharmaceutical Research and Manufacturers of America, Plaintiffs-Appellants, v. William H. SORRELL, as Attorney General of the State of Vermont, Jim Douglas, in his official capacity as Governor of the State of Vermont, and Robert Hofmann, in his capacity as Secretary of the Agency of Human Services of the States of Vermont, Defendants-Appellees.

United States Court of Appeals, Second Circuit.

Decided: November 23, 2010.

Attorney(s) appearing for the Case

Thomas R. Julin , Jamie Z. Isani , Patricia Acosta , Hunton & Williams LLP, Miami, FL; Robert B. Hemley , Matthew B. Byrne , Gravel & Shea, P.A., Burlington, VT; Thomas C. Goldstein , Akin Gump Strauss Hauer & Feld LLP, Washington, DC, for Plaintiffs-Appellants IMS Health Inc. and Source Healthcare Analytics, Inc.

Mark A. Ash , Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan, LLP, Raleigh, NC, for Plaintiff-Appellant Verispan LLC.

Robert N. Weiner , Jeffrey L. Handwerker , Sarah Brackney Arni , Arnold & Porter LLP, Washington, DC; Karen McAndrew , Linda J. Cohen , Dinse, Knapp & McAndrew, P.C., Burlington, VT, for Plaintiff-Appellant Pharmaceutical Research & Manufacturers of America.

William H. Sorrell , Attorney General of the State of Vermont; Bridget C. Asay , Assistant Attorney General; Sarah E.B. London , Kate G. Duffy , David R. Cassetty , Assistants Attorneys General, on the brief, Montpelier, VT, for Defendants-Appellees.

Judge LIVINGSTON dissents in a separate opinion.

JOHN G. KOELTL, District Judge:

The appellants, IMS Health Inc., Verispan, LLC, Source Healthcare Analytics, Inc., and Pharmaceutical Research and Manufacturers of America ("PhRMA") (collectively, "the appellants") challenge a Vermont statute banning the sale, transmission, or use of prescriber-identifiable data ("PI data") for marketing or promoting a prescription drug unless the prescriber consents. In 2007, Vermont enacted the statute at issue, namely Vt. Acts...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases